Syncom is experienced in custom synthesis of beta-lactam compounds. A range of antibacterial compounds such as penem pro-drugs and derivatives such as carbopenem, faropenem, meropenem, sulopenem and oxapenem have been synthesized by our highly experienced chemists. In the field of cephalosporines, impurities of cefpodoxim and new derivatives of cephalosporin are specialties of Syncom.
Syncom has developed many medchem routes for novel beta-lactam compounds duringroute development and custom synthesis projects. Our chemists have also converted existing beta-lactam medchem routes into scalable process routes up to multi kg quantities during process research projects.
In order to prevent cross-contamination, antibiotic projects are executed in a separate, dedicated high potency lab by highly experienced chemists.